These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8579100)
21. Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells. Thibodeaux DK; Hunter SE; Waldburger KE; Bliss JL; Trepicchio WL; Sypek JP; Dunussi-Joannopoulos K; Goldman SJ; Leonard JP J Immunol; 1999 Nov; 163(10):5257-64. PubMed ID: 10553047 [TBL] [Abstract][Full Text] [Related]
22. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats. Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538 [TBL] [Abstract][Full Text] [Related]
23. Commitment of individual Th1-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10: selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4. Assenmacher M; Löhning M; Scheffold A; Richter A; Miltenyi S; Schmitz J; Radbruch A J Immunol; 1998 Sep; 161(6):2825-32. PubMed ID: 9743342 [TBL] [Abstract][Full Text] [Related]
24. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression. Kurzawa H; Wysocka M; Aruga E; Chang AE; Trinchieri G; Lee WM Cancer Res; 1998 Feb; 58(3):491-9. PubMed ID: 9458095 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455 [TBL] [Abstract][Full Text] [Related]
26. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages. Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827 [TBL] [Abstract][Full Text] [Related]
27. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. Hogaboam CM; Chensue SW; Steinhauser ML; Huffnagle GB; Lukacs NW; Strieter RM; Kunkel SL J Immunol; 1997 Dec; 159(11):5585-93. PubMed ID: 9548500 [TBL] [Abstract][Full Text] [Related]
28. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954 [TBL] [Abstract][Full Text] [Related]
29. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Beshay E; Croze F; Prud'homme GJ Clin Immunol; 2001 Feb; 98(2):272-9. PubMed ID: 11161985 [TBL] [Abstract][Full Text] [Related]
30. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Xiao BG; Ma CG; Xu LY; Link H; Lu CZ Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10. Ruetten H; Thiemermann C Shock; 1997 Dec; 8(6):409-14. PubMed ID: 9421853 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. Brenner T; Brocke S; Szafer F; Sobel RA; Parkinson JF; Perez DH; Steinman L J Immunol; 1997 Mar; 158(6):2940-6. PubMed ID: 9058833 [TBL] [Abstract][Full Text] [Related]
33. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Ramírez F; Mason D Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389 [TBL] [Abstract][Full Text] [Related]
34. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798 [TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
37. Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. Koblish HK; Hunter CA; Wysocka M; Trinchieri G; Lee WM J Exp Med; 1998 Nov; 188(9):1603-10. PubMed ID: 9802972 [TBL] [Abstract][Full Text] [Related]
38. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model. Ren X; Li J; Zhou X; Luo X; Huang N; Wang Y; Chen X; Wei Y Dermatology; 2009; 219(3):232-8. PubMed ID: 19729876 [TBL] [Abstract][Full Text] [Related]
39. Enhanced survival during experimental Listeria monocytogenes sepsis in neonatal mice prophylactically treated with Th1 and macrophage immunoregulatory cytokines and mediators. Geyer MB; Radhakrishnan K; Van de Ven C; Suri MS; Ayello J; Cairo MS Pediatr Infect Dis J; 2014 Dec; 33(12):e330-7. PubMed ID: 24911893 [TBL] [Abstract][Full Text] [Related]
40. Effect of staphylococcal enterotoxin B injection on the development of experimental autoimmune encephalomyelitis: influence of cytokine and inducible nitric oxide synthase production. Kuschnaroff LM; Overbergh L; Sefriouni H; Sobis H; Vandeputte M; Waer M J Neuroimmunol; 1999 Oct; 99(2):157-68. PubMed ID: 10505970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]